Plinio Fabiani

comorbidities renal failure frailty padua risk score venous thromboembolism fondaparinux prophylaxis improve risk score atrial fibrillation prevenzione embolia polmonare linee guida anticoagulanti preserved ejection fraction frazione di eiezione conservata scompenso cardiaco osas copd anemia diabetes obesity exercise training therapy hfref hfpef heart failure qaly economic burden chronic heart failure chf life expectancy milrinone dopamine ahf clinical profiling diuretics acute heart failure enoximone inotropic agents phosphodiesterase iii inhibitors dobutamine european society of cardiology first line peripheral hypoperfusion furosemide levosimendan pharmacotherapy pharmacological treatment vasodilator congestion esc basal insulin and glp-1 ras combinations stress hyperglycemia acutely ill diabetic patients glulisine glargine u300 detemir glargine glycemic targets degludec yale protocol lispro new insulin analogues hospitalised patients low molecular weight heparin practice guidelines older patients pulmonary embolism elba island risk management dvt deep vein thrombosis tuscany lmwh tachicardia arrhythmias hypothyroidism heart attack bradicardia cardiovascular risk subclinical overt hyperthyroidism thrombi transoesophageus acute stroke echocardiography clots transthoracic dipiridamolo rischio emorragico ictus aspirina clopidogrel stroke trombolisi